WallStreetZenWallStreetZen

NASDAQ: VCYT
Veracyte Inc Stock Ownership - Who owns Veracyte?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Veracyte Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Marc StapleyChief Executive Officer2026-03-0419,244$35.56
$684.22kSell
Annie McGuireSVP General Counsel2026-03-041,664$36.34
$60.47kSell
Rebecca ChambersChief Financial Officer2026-03-044,400$35.55
$156.41kSell
Rebecca ChambersChief Financial Officer2026-03-0413,941$36.33
$506.46kSell
Annie McGuireSVP General Counsel2026-03-044,994$35.29
$176.26kSell
John LeiteChief Commercial Officer-CLIA2026-03-045,260$35.19
$185.08kSell
Marc StapleyChief Executive Officer2026-03-0426,279$36.28
$953.38kSell
John LeiteChief Commercial Officer-CLIA2026-03-027,517$36.01
$270.69kSell
Phillip G. FebboChief Scientific Med Officer2026-03-026,035$36.01
$217.32kSell
Marc StapleyChief Executive Officer2026-03-0219,455$36.01
$700.57kSell

1 of 8

VCYT insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VCYT insiders and whales buy or sell their stock.

VCYT Shareholders

What type of owners hold Veracyte Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc16.52%13,128,801$434.43MInstitution
Vanguard Group Inc10.70%8,504,011$281.40MInstitution
Artisan Partners Limited Partnership7.88%6,263,041$207.24MInstitution
Fmr LLC7.22%5,738,209$189.88MInstitution
State Street Corp5.49%4,360,913$144.30MInstitution
Ark Investment Management LLC4.89%3,887,547$128.64MInstitution
Versant Ventures III LLC4.55%3,616,221$119.66MInsider
Brian G. Atwood4.55%3,616,221$119.66MInsider
Samuel D. Colella4.55%3,616,221$119.66MInsider
Tpg Group Holdings Sbs Advisors Inc4.47%3,551,929$117.53MInsider

1 of 3

VCYT vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VCYT66.85%33.15%Net SellingNet Selling
IMNM93.77%6.23%Net SellingNet Selling
IRON60.49%39.51%Net SellingNet Selling
TARS72.94%27.06%Net SellingNet Selling
KOD73.02%26.98%Net BuyingNet Buying
View Top Biotech Stocks

Veracyte Stock Ownership FAQ

Who owns Veracyte?

Veracyte (NASDAQ: VCYT) is owned by 109.23% institutional shareholders, 54.15% Veracyte insiders, and 0.00% retail investors. Versant Ventures III LLC is the largest individual Veracyte shareholder, owning 3.62M shares representing 4.55% of the company. Versant Ventures III LLC's Veracyte shares are currently valued at $119.66M.

If you're new to stock investing, here's how to buy Veracyte stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.